In osteoporosis pharmaceutical agents are used to minimize further bone loss. Basically there is a progressive diminution of bone density This causes skeletal weakness and a predisposition to fractures. Basically, in normal bone bone formation and bone resorption are closely coupled. When the rate of resorption exceeds the rate of formation there is a decrease in bone mass. The amount of bone necessary to mechanically support the skeleton eventually falls below the fracture threshold.
There are many degrees of osteoporosis and treatments available. I am not qualified to suggest a specific treatment. Calcium and vitamin D3 supplements are helpful, but in some cases the problem is the mechanism by which bone is created.
Three types of osteoporosis exist and the treatments vary with the etiology,
Idiopathic, with no known cause is uncommon.
Type I, or postmenopausal occurs in women between 51 and 75 years of age. It can occur in men with low levels of testosterone. Estrogen deficiency is a significant cause of bone loss.
Type II, called involutional or senile osteoporosis is associated with the normal process of aging.,
Steroidal osteoporosis will not result from ocasional use of steroids. The doses must be high and continue over a long period of time
I am not about to suggest a treatment protocol. Input is always appreciated. The drugs I mentioned were only mentioned in order to point out there are a variety of interventions.
In point of act, in addition of calcium and D3, however this should be done under the supervision of a physician because there is a remote possibility of hypercalcemia, hypercalciuria and renal failure.
Women are often treated with estrogen, with or without progestin.
Women who cannot tolerate estrogen are sometimes treated with salmon calcitonin, available in parenteral and nasal spray.
Commonly drugs known as bisphosphonates are used, which inhibit osteoclast-mediated bone resorbtion. Another drug called alendronate has also been apoproved.
My only point in mentioning these treatments is to reassure that a diagnosis does not mean one should give o hope or become depressed.
Non-pharmaceutical treatment includes avoidance of caffeine and alcohol, limit smoking, avoid long-acting benzodiazapines, maintaining good nutrition and body weight, and treatment of impaired visual function. Be vary careful about the risk of falls.
Moderate daily exercise, to include walking and isometrics are helpful because mild stress on bones stimulate the growth mechanism. The goal of treatment is to prevent fractures, decrease pain, and maintain function.
Men with osteopororis also require evaluation for androgen deficiency.
Zoledronic acid is used only for most extreme cases, and for cancer metastases that are osteoblastic. It effectively wipes out most of patient's osteoclasts, leaving the body unable to dissolve bone tissue that's produced by osteoblasts. I never understood the reasoning behind this in case of bone-filling cancers...
thankyou guys
i will ask my doctor about all things and will diskuss with u
Osteoporosis is definitely not a cancer. The bones become weak and brittle and subject to fractures.
A common cause is use of oral steroids such as prednisone in excess of three months.
The bright spot is there are several treatment options to include parathyroid hormone and zoldronic acid.
I don't have enough knowledge to suggest a specific treatment protocol, however this is definitely something you should discuss with your primary care physician.
Osteoporosis is NOT bone cancer.
As we age the bones can lose density and become weak and fragile. With a weakened bone, any fall could result in a fracture.
Fractures most commonly occur in the spine, wrist and hips, other bones such as the arm or pelvis can also be affected.
If you and someone you know has osteoporosis, the doctor will normally prescribe calcium and vitamin D to be taken every day.
Calcium builds up the bones and Vitamin D helps the body to absorb the calcium.
Calcium and Vitamin D from dietary sources may not be enough to help the weak and fragile bones.